The automatic cell counters help with this early diagnosis. Additionally, the market is being stimulated by the biopharma vertical’s ongoing research.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 09, 2024 (GLOBE NEWSWIRE) — The automated cell counters market (Markt für automatisierte Zellzähler) was projected to attain US$ 3.4 billion in 2023. It is likely to garner a 5.3% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 6.1 billion.
An important instruments for the production of biopharmaceuticals and bioprocessing is the automated cell counter. They are made to assist in satisfying the requirements for accurate cell counts without the unpredictability of manual hemocytometer counting.
The automatic cell counters can be self-contained (internal PC) or linked to external PCs. Precise volumetric counts are possible when the sample is kept in a disposable consumable (cartridge or slide) that ensures the same volume is evaluated each time.
In addition to being utilized in pharmaceutical research and medical diagnostics, automated cell counts may also be employed in food quality monitoring. Techniques for consistently and, more precisely, studying cells include flow cytometry and digital imaging.
Request for sample PDF copy of report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73758
Key Findings of Market Report
- A major factor driving the market for automated cell counts is the rise in the incidence of chronic illnesses, including diabetes, cancer, and cardiovascular diseases. Blood cell counts must be continuously monitored for chronic illnesses.
- According to a WHO study from 2022, non-communicable or chronic illnesses account for 41 million deaths annually. In pathology laboratories, research facilities, and hospitals, automated cell counters improve the efficiency and precision of cell counts.
- Additionally, since medical professionals may immediately begin therapy, automated cell counters aid in the early discovery of abnormal blood cell counts, which may assist in halting the progression of a disease once it has been detected.
Market Trends for Automated Cell Counters
- The biopharma industry’s focus on drug development and cell-based research is driving up demand for automated cell counts. High-class cytotoxicity screening tests may be carried out to assess both the toxicity and effectiveness of drugs thanks to high-throughput automated cell counting devices.
- To expedite their research and development initiatives, a number of top pharmaceutical companies are choosing to implement automated solutions.
- Furthermore, research on immunology and stem cells is receiving more financing from the public and commercial sectors, which is propelling the worldwide automated cell counter market upward. For single cell examination, phenotypic characterization, and cell sorting, automated counting instruments are advised.
- For example, the National Institutes of Health (NIH) approved about US$ 41 billion in funding for medical research in 2021 for labs and institutions across the United States, with a significant amount going toward cell-based research initiatives.
Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73758
Global Market for Automated Cell Counters: Regional Outlook
- The automated cell enumeration tools market was led by North America in 2023, and this trend is anticipated to continue during the forecast period, according to the most recent automated cell counters industry data.
- This is ascribed to the United States’ robust research and development infrastructure, which promotes biotechnology and life sciences innovation.
- The market expansion for automated cell counters in Asia Pacific is a result of nations like Japan placing a strong emphasis on in-depth study in the healthcare sector. When it comes to funding biotechnology research and development, China and India are likewise making progress.
Automated Cell Counters Market: Competitive Landscape
To remain competitive in the automated cell counters industry, manufacturers are launching innovative products. For example, two specific nuclei counting applications for CellDrop Automated Cell Counters were released by DeNovix Inc. in August 2022.
They are able to discriminate between single nuclei from remnants and whole cells. The following companies are well-known participants in the automated cell counters market:
- Thermo Fisher Scientific Inc.
- Countstar
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- ChemoMetec A/S
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Sysmex Corporation
- Agilent Technologies, Inc.
- Abbott Laboratories
- Others
Key Developments
- The DeNovix CellDrop Automated Cell Counter received “ACT Label certification” in October 2023 from My Green Lab.
- Thermo Fisher Scientific introduced closed and automated bead removal and cell separation systems in October 2022 to support the production of cell therapy. This method achieves scalable cell therapy manufacturing by improving cell purity, isolation efficacy, and targeted cell recovery.
Global Automated Cell Counters Market Segmentation
Product
- Instruments
- Consumables and Accessories
- Software
Application
- Medical Diagnostics
- Drug Discovery
- Bioprocessing Industries
- Food & Beverages Industry
- Others
End User
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotech Companies
- Research Institutes
- Others
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=73758<ype=S
More Trending Reports by Transparency Market Research –
Dental Implant Motors Market (치과용 임플란트 모터 시장) – The global dental implant motors market is expected to grow at a CAGR of 3.5% during the forecast period from 2021 to 2031.
Urometer Market (ウロメーター市場) – The global urometer market is projected to flourish at a CAGR of 6.8% from 2022 to 2032. As per the report published by TMR, a valuation of US$ 987.7 million is anticipated for the market in 2032. As of 2023, the market for urometer is expected to close at US$ 547.6 million.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
- XRP Ledger Payment Volume Skyrockets Over 1,000%, Analysts Expect Similar For Remittix (RTX) - June 15, 2025
- Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman - June 15, 2025
- EGBN Investor News: If You Have Suffered Losses in Eagle Bancorp, Inc. (NASDAQ: EGBN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - June 15, 2025
